1. Home
  2. RGEN vs ESLT Comparison

RGEN vs ESLT Comparison

Compare RGEN & ESLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ESLT
  • Stock Information
  • Founded
  • RGEN 1981
  • ESLT 1966
  • Country
  • RGEN United States
  • ESLT Israel
  • Employees
  • RGEN N/A
  • ESLT N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ESLT Military/Government/Technical
  • Sector
  • RGEN Health Care
  • ESLT Industrials
  • Exchange
  • RGEN Nasdaq
  • ESLT Nasdaq
  • Market Cap
  • RGEN 8.2B
  • ESLT 22.6B
  • IPO Year
  • RGEN N/A
  • ESLT 1996
  • Fundamental
  • Price
  • RGEN $171.37
  • ESLT $464.38
  • Analyst Decision
  • RGEN Buy
  • ESLT Buy
  • Analyst Count
  • RGEN 11
  • ESLT 2
  • Target Price
  • RGEN $170.90
  • ESLT $530.00
  • AVG Volume (30 Days)
  • RGEN 894.6K
  • ESLT 102.4K
  • Earning Date
  • RGEN 10-28-2025
  • ESLT 11-18-2025
  • Dividend Yield
  • RGEN N/A
  • ESLT 0.58%
  • EPS Growth
  • RGEN N/A
  • ESLT 68.63
  • EPS
  • RGEN 0.03
  • ESLT 9.87
  • Revenue
  • RGEN $707,890,000.00
  • ESLT $7,720,284,000.00
  • Revenue This Year
  • RGEN $17.50
  • ESLT $18.56
  • Revenue Next Year
  • RGEN $12.74
  • ESLT $11.03
  • P/E Ratio
  • RGEN $6,738.58
  • ESLT $47.05
  • Revenue Growth
  • RGEN 11.74
  • ESLT 18.35
  • 52 Week Low
  • RGEN $102.97
  • ESLT $243.18
  • 52 Week High
  • RGEN $182.52
  • ESLT $529.99
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 68.21
  • ESLT 42.46
  • Support Level
  • RGEN $146.56
  • ESLT $457.27
  • Resistance Level
  • RGEN $154.82
  • ESLT $475.55
  • Average True Range (ATR)
  • RGEN 7.03
  • ESLT 16.23
  • MACD
  • RGEN 1.69
  • ESLT -0.82
  • Stochastic Oscillator
  • RGEN 93.47
  • ESLT 12.83

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About ESLT Elbit Systems Ltd.

Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.

Share on Social Networks: